Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS32582 capsule study in adults with moderate to severe plaque psoriasis
CTR20252671Phase 2Active
- Sponsor
- Chipscreen Biosciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in plaque psoriasis comparing CS32582 capsule with Placebo (2 arms). Started Sep 2025; status: active.
02
Drugs
CS32582
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20252671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252671.